ArticleInternational journal of epidemiology2026
Estimating causal effects of C-reactive protein on disease and health outcomes using multivariable Mendelian randomization adjusting for heritable confounding.
Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundC-reactive protein (CRP) is a marker of inflammation associated with autoimmune, cardiovascular, and neuropsychiatric disorders. However, it remains unclear whether CRP causally affects these traits or if observed associations result from reverse causation or confounding. Mendelian randomization (MR) uses genetic variants as instrumental variables to estimate causal effects and avoid the biases present in observational studies. Prior MR studies have suggested causal effects of CRP on several traits, including low-density lipoprotein (LDL) cholesterol, schizophrenia (SCZ), and knee osteoarthritis (OA). However, MR may produce biased results if traits that confound the exposure and outcome are heritable, resulting in horizontal pleiotropy. This is a major concern for studies of CRP, because CRP levels may increase in response to inflammation caused by a wide range of heritable conditions.
methodsMultivariable Mendelian randomization (MVMR) can be used to eliminate bias from heritable confounding when genome-wide association study (GWAS) summary data are available for confounders. In this study, we used MVMR to estimate the causal effects of CRP on 16 outcomes with prior evidence of a causal or associational link to CRP. We used a novel computational pipeline to identify a broad set of potential heritable confounders between CRP and each outcome trait from studies in the Medical Research Council Integrative Epidemiology Unit (MRC-IEU) OpenGWAS database. We compared MVMR results with computationally selected confounders to univariable MR results and MVMR adjusting only for body mass index.
resultsUnivariable MR suggests evidence of potential causal effects of CRP on coronary artery disease, high-density lipoprotein (HDL) cholesterol, LDL cholesterol, triglycerides, type 2 diabetes, glycated hemoglobin (HbA1c), rheumatoid arthritis (RA), SCZ and OA at the nominal P < .05 significance level. However, after adjusting for computationally selected heritable confounders, only effects on HDL cholesterol (negative), HbA1c (positive), RA (risk increasing), and SCZ (risk decreasing) remain nominally significant. Using confounder-adjusted MVMR additionally reveals evidence of a protective effect of CRP on bipolar disorder not observed in the univariable analysis.
conclusionThese results suggest that univariable MR analyses of CRP may be biased by high levels of heritable confounding, though CRP may indeed play a causal role in development of some diseases, potentially mediated by its role in innate immunity. These results also highlight the potential for automatic confounder selection to improve the robustness of MR analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.